Reimagining the regulation of informal pharmaceutical markets: The importance of pragmatic expertise and improvisation in Nigeria

Drug-induced upper gastrointestinal bleeding: A real-world pharmacovigilance study

MHRA Drug Safety Update: Falsified Mounjaro KwikPen 15mg pre-filled pens

Puberty blockers: Controversial trial paused over safety concerns

Redefining polypharmacy: Shifting from drug counts to patient-centered clinical appropriateness

Long‐Term Adherence and Drug Utilisation Patterns Among New Users of Anti‐Hyperlipidemic Monotherapy: Development of a Risk Prediction Model

Cómo la Industria Farmacéutica Influye en la Producción de Evidencias Científicas: Manipulación de Investigaciones y Escritura Fantasma (ghostwriting)

Systematic modeling predicts synergistic and safe drug combinations for parasitic diseases

Prospective Study of Adverse Drug Reactions in Patients with Bipolar Disorder at a tertiary centre

Potential utility of social media in pharmacovigilance to identify adverse events and safety signals: a scoping review

Aquatic ecotoxicology in a climate change scenario to support ecopharmacovigilance of veterinary antibiotics

Digital medicine for infectious diseases

Comparison of Adverse Events Associated With Six Common Antibiotics in Lower Respiratory Tract Infections Using the United States Food and Drug Administration Adverse Event Reporting System

Contributions of Pharmacovigilance to the Understanding of Risks Associated with Ibuprofen: Descriptive and Disproportionality Analysis Using FAERS Data

Artificial Intelligence for Drug Safety Across the Lifecycle and Decision Type: A Scoping Review

Comparative disproportionality signals for methotrexate monotherapy versus methotrexate combined with hydroxychloroquine, leflunomide, or sulfasalazine in rheumatoid arthritis: newly highlighted signals evaluated using drug information safety profiles

Dosis letal: cómo se mide la seguridad de un medicamento

Potential risk signals for drug-related osteomyelitis: a comprehensive disproportionality analysis based on the FDA Adverse Event Reporting System (FAERS) database

A pharmacovigilance analysis of carbapenem-related utilizing the FDA adverse event reporting system (FAERS) database from 2013 to 2025

Exploratory analysis of real-world use and safety of traditional Korean medicine in pediatric epilepsy: A retrospective observational study

Prenatal exposure to antiseizure medications and risk of autism spectrum disorder in offspring: an integrated pharmacovigilance and two-sample mendelian randomization study

Navigating drug–drug interactions with apalutamide

Artificial intelligence-based incident analysis and learning system to enhance patient safety and improve treatment quality

Selective oestrogen receptor modulators and Alzheimer´s disease: a real-world pharmacovigilance study

Unveiling the hidden risks of nanomedicine-based drug delivery: a comparative evaluation of drug safety profiles of liposomal irinotecan and conventional irinotecan

Empowering citizens to spontaneously report suspected adverse drug reaction: Systematic literature review of interventions and their impact

Assessing safety trends of withdrawn medications: A data-driven pharmacovigilance approach using growth models

Analysis of interstitial lung disease in pharmacovigilance databases: Coding challenges and interpretation biases—An update

Fondos Rotatorios: un mecanismo clave para garantizar la disponibilidad y seguridad de vacunas y medicamentos en el Perú

Navigating Polypharmacy: A Patient-Focused Guide to Safer Medication Use

What if most medications were sold over-the-counter?